Boehringer Ingelheim is involved in research, development, manufacturing, and marketing of pharmaceuticals. self-described.

Boehringer Ingelheim

Boehringer Ingelheim | 1,865,766 followers on LinkedIn. Our people are our strength. And, together with over 53,000 colleagues, we&#39;re creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us?

Gwen Whitfield Foster

Research Data Management - Lab Services Engineer at Boehringer-Ingelheim

Thomas Macauley

Highly Distinguished Research Fellow

Mitchell Taub

Innovative Product Leader | Pioneering GenAI-Driven Data, Analytics and Application Platforms | ex Salesforce | HIRING

Ralf Schundelmeier

Obesity is a gateway disease into other cardiovascular, renal, and metabolic diseases. It affects over 1 billion people in the world with numbers continuing to rise. We are working as part of the Innovative Health Initiative (IHI) consortium IMI_SOPHIA to identify biomarkers connected with higher cardiometabolic risk in obesity. Learn more about this groundbreaking research published in Nature Medicine and how this could enable precision prevention of cardiometabolic diseases in people living with obesity: https://rdcu.be/dXXoI #Research #PrecisionMedicine #Obesity

It’s staggering to think that 1 in 10 people worldwide live with chronic kidney disease (CKD) - but we’re on a mission to prevent disease progression and associated complications. In his latest article, our colleague Sandy Sommer , Head of the Therapeutic Area Cardiovascular, Renal, & Metabolic, shares our vision for the future of CKD care: developing breakthrough treatments that improve the lives of people affected by CKD and connected cardiovascular, renal and metabolic conditions. Discover more here: https://bit.ly/4fiS2vX #LifeForward #ChronicKidneyDisease #KidneyHealth

He is a Boehringer legend: Michael Mark studied pharmacy in Tübingen, received his PhD and worked as a postdoc – until he decided to switch from academia to the pharmaceutical industry. To us. As the brain behind one of our most important medicines, the pharmacologist remained with our company until his retirement in 2019. A total of 34 years, including 19 years as Head of Cardio-metabolic Diseases Research. To this day, his breakthroughs in pharmaceutical research have shaped and improved the lives of millions of patients 💊 👉🏻 Learn more about Michael's success story in our video: https://lnkd.in/eA4Vu7ds

Our "Annual Report Magazine" and "Corporate Brand Design Relaunch" won the Red Dot Design Award 2024! Each design work, from concept to execution, is a creative and collaborative journey. Our big thank you goes to the agencies we worked with on these projects - 3st kommunikation and Interbrand . Take a look at the winning publication: https://lnkd.in/e7rsAUv3 #annualreport #reddotaward #designaward

We are joining forces with the Broad Institute of MIT and Harvard to address the sleep disturbances that contribute to cognitive impairment. Jointly we will work on treatments to normalize sleeping patterns to bring cognitive and real-world benefits to people with mental health disorders. Learn more: http://bit.ly/4fwXoDT #ResearchCollaboration #Innovation #MentalHealth

42 per cent of Mexicans do not have access to clean water. That negatively impacts their health. Since 2022, we have been partnering with an NGO to build water harvesting systems in underserved communities. Meet our volunteers who were on a mission in Ranchito, a small neighborhood in Mexico City. 👇 Read more here: https://lnkd.in/epTiHDUx #OneHealth #LifeForward

This #LungCancerAwarenessMonth , our patient advocates address top questions about lung cancer, providing clarity and guidance. Stigma still hinders many from seeking needed support and care. Our interviews reveal true perceptions and the urgent need for change. Together, let's transform the narrative and support those affected: https://lnkd.in/eKihZEje #LCAM Lung Cancer Europe , WALCE APS , GO2 for Lung Cancer and Respirando con Valor

The health of humans, animals and the environment are closely inter-dependent. We're aiming for a future where humans and animals live healthier lives. Learn more in our video. 👇 #LifeForward #OneHealth #OneHealthDay

When suffering a stroke, every minute counts. Delays can lead to severe disabilities or death, so great teamwork is key. Jorge from Brazil experienced a stroke while making coffee. Explore how we are transforming stroke care for him and millions of other patients around the globe through our Angels Initiative here: https://lnkd.in/epnqaXax #LifeForward #HealthforAll

Breaking the stigma around mental health starts with us. And to do so, we need more role models in serious mental illness – that’s the message from Roi Sternin , a patient expert from Austria. While many people openly discuss their physical or visible illnesses, only a few speak up about serious mental health conditions. Break the stigma! Learn more about misconceptions in serious mental health conditions: https://lnkd.in/e8RqB8-4

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 7, 2024 4:18 AM	bef72957
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 7, 2024 4:18 AM	e7c4f080
crunchbase trigger	general	Nov 7, 2024 4:18 AM	38468053
crunchbase profile	general
li profile	general	Nov 7, 2024 4:18 AM	0f4713dc
translate crunchbase fundingrounds	general
peers	general	Nov 7, 2024 4:18 AM	5853d909
news basic	general	Nov 7, 2024 4:18 AM	794764f5
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

BOEH

COM:BOEHRINGER-INGELHEIM

Boehringer Ingelheim